Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nestle sales & earnings

This article was originally published in The Tan Sheet

Executive Summary

Nestle's Nutrition sales grew 6.1% to 6 bil. Swiss Francs ($4.68 bil.) helped by an improvement in China, while total sales for 2006 were 98.5 bil. Swiss Francs ($79.8 bil.) up 8.1%. The Switzerland-based firm achieved strong gains in infant nutrition as a result of the international roll-out of infant formula product Nestle NAN HA, according to a sales and earnings report. "We are seeing the benefits of the group's transformation into a nutrition, health and wellness company, with stronger innovation and branding, as well as improved efficiency," Nestle Chairman and CEO Peter Brabeck-Letmathe says. Products enriched with Branded Active Benefits achieved organic growth of more than 20% in 2006 with sales close to 4 bil. Swiss Francs ($3.24 bil.), the company says. Nestle says beverages achieved 8% organic growth to 25.9 bil. Swiss Francs ($21 bil.)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS100254

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel